U.S. market for dental bone graft substitutes is expected to witness significant growth due to the increasing prevalence of dental diseases and sophisticated healthcare infrastructure.
Canada is also experiencing growth in the dental bone graft substitutes market, attributed to the rise in dental surgeries and the availability of advanced dental treatments.
Asia Pacific:
China is anticipated to dominate the Asia Pacific dental bone graft substitutes market, owing to the large patient population, rising disposable income, and growing awareness about dental healthcare.
Japan and South Korea are also expected to contribute significantly to the market growth, driven by the presence of key market players and increasing investments in the dental healthcare sector.
Europe:
United Kingdom, Germany, and France are projected to lead the European dental bone graft substitutes market, supported by the presence of leading dental implant companies, high healthcare expenditure, and favorable reimbursement policies.